Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Recurrence 1Polycythemia Vera 1Polycythemia 1Ovarian Neoplasms 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2sargramostim 1lestaurtinib 1fludarabine phosphate 1Vorinostat 1Tacrolimus 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Ketamine 1Histone Deacetylase Inhibitors 1Filgrastim 1Carboplatin 1Busulfan 1Antilymphocyte Serum 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thrombocythemia, Essential × Vorinostat × Clear all
NCT00866762 2011-12-12

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Copenhagen University Hospital at Herlev

Phase 2 Unknown
60 enrolled
Myeloid

Hematologic Diseases, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡